The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

Jun. 08, 2023
Applicant:

Mesoblast International Sárl, Meyrin, CH;

Inventors:

Samson Tom, Basking Ridge, NJ (US);

Christopher Ton, Lansdale, PA (US);

Alla Danilkovitch, Columbia, MD (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0775 (2010.01); A61K 35/12 (2015.01); A61K 35/28 (2015.01); A61K 41/00 (2020.01); A61K 47/69 (2017.01); A61K 49/04 (2006.01); A61K 49/18 (2006.01); A61P 37/06 (2006.01); B82Y 5/00 (2011.01); A61M 37/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0663 (2013.01); A61K 35/28 (2013.01); A61K 41/0038 (2013.01); A61K 41/0052 (2013.01); A61K 47/6901 (2017.08); A61K 49/0423 (2013.01); A61K 49/1827 (2013.01); A61P 37/06 (2018.01); B82Y 5/00 (2013.01); A61K 2035/122 (2013.01); A61M 37/00 (2013.01); C12N 2511/00 (2013.01);
Abstract

The present invention provides preparations of MSCs with important therapeutic potential. The MSC cells are non-primary cells with an antigen profile comprising less than about 1.25% CD45+ cells (or less than about 0.75% CD45+), at least about 95% CD105+ cells, and at least about 95% CD166+ cells. Optionally, MSCs of the present preparations are isogenic and can be expanded ex vivo and cryopreserved and thawed, yet maintain a stable and uniform phenotype. Methods are taught here of expanding these MSCs to produce a clinical scale therapeutic preparations and medical uses thereof.


Find Patent Forward Citations

Loading…